Radiother Oncol. 2020 Sep 2:S0167-8140(20)30755-6. doi: 10.1016/j.radonc.2020.08.026. Online ahead of print.
Technical improvements in head and neck cancer radiotherapy over the last decade have resulted in substantial reductions in dose to organs-at-risk. For a mix of tumors, we saw less xerostomia moving from 3D-conformal to more advanced techniques. For oropharynx-only there were additional improvements, including in global quality-of-life and sticky saliva.